MCC
VBIV

Money Concepts Capital’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Money Concepts Capital’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-87
Closed -$1.02K – 3078
2022
Q4 		$1.02K Buy
+87
New +$1.53K ﹤0.01% 2878
2022
Q2 		– Sell
-33
Closed -$2K – 2711
2022
Q1 		$2K Buy
+33
New +$1.63K ﹤0.01% 2509

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Money Concepts Capital's VBIV Position: Q1 2023 in Review

Money Concepts Capital sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2023, closing a stake of 87 shares — an estimated $1.02K sold.

Money Concepts Capital first reported a position in VBIV in Q1 2022 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 95 funds tracked by Wall St. Rank hold VBIV as of Q1 2023.

  • Money Concepts Capital reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 87 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2023, an estimated $1.02K.
  • Money Concepts Capital first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2022 and held it in 2 quarters.
  • Money Concepts Capital's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q1 2022.
  • 95 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.